Literature DB >> 9053738

Stereoselective effects of mexiletine enantiomers on sodium currents and excitability characteristics of adult skeletal muscle fibers.

A De Luca1, F Natuzzi, G Lentini, C Franchini, V Tortorella, D Conte Camerino.   

Abstract

The effects of the enantiomers of mexiletine were tested on sodium currents of frog skeletal muscle fibers recorded by means of the three vaseline gap voltage clamp method and compared with the effects produced by tocainide enantiomers. The R-(-) mexiletine produced a tonic block of the sodium current, elicited by single depolarizing test pulses from the holding potential of -100 mV to -20 mV, with an IC50 of 43.9 +/- 1 microM, whereas the corresponding S-(+) enantiomer produced the same effects at about twofold higher concentrations. A similar steroselectivity was observed with tocainide enantiomers, but at about 5 fold higher concentrations. Both the R-(-) and S-(+) enantiomers of mexiletine and tocainide produced a further use-dependent block of sodium currents when the test pulse was applied repetitively at a frequency of 2 Hz. The use dependent behavior led to a significant lowering of the IC50 values with respect to the tonic block but the eudismic ratios ([IC50S-(+)]/[IC50R(-)]) and the relative potency between mexiletine and tocainide were maintained. All the tested compounds produced a left shift of the steady state inactivation curves (h infinity), suggesting a high-affinity interaction with the inactivated sodium channels. Again a stronger potency of R-(-) vs. S-(+) enantiomers and of mexiletine vs. tocainide was observed. The excitability characteristics recorded from the semitendinosus muscle by the two microelectrode technique were modified by the tested drugs in agreement with their ability to block sodium current. Thus a concentration-related increase in the threshold current required to elicit an action potential as observed along with a decrease in the amplitude and a shortening of the latency of action potential and a decrease in the firing capability of the membrane. Again the R-(-) isomers were more potent than the S-(+) ones and mexiletine was more effective than tocainide. These data corroborate the presence of a stereospecific site for these drugs on adult skeletal muscle sodium channels. The constant eudismic ratios between the enantiomers during both tonic and use-dependent block suggest that the increase in the apparent affinity of the receptor during state-dependent conformational changes of the channel does not enhance its stereospecificity. The decrease in effective concentration upon high frequency stimulation supports the potential usefulness of low doses of R-(-) mexiletine in the treatment of the abnormal hyperexcitability of the myotonic muscles, with a likely reduction of unwanted side effects.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9053738     DOI: 10.1007/BF00171325

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  37 in total

1.  An improved vaseline gap voltage clamp for skeletal muscle fibers.

Authors:  B Hille; D T Campbell
Journal:  J Gen Physiol       Date:  1976-03       Impact factor: 4.086

2.  Opposite effects of enantiomers of clofibric acid derivative on rat skeletal muscle chloride conductance: antagonism studies and theoretical modeling of two different receptor site interactions.

Authors:  A De Luca; D Tricarico; R Wagner; S H Bryant; V Tortorella; D Conte Camerino
Journal:  J Pharmacol Exp Ther       Date:  1992-01       Impact factor: 4.030

3.  Structural parts involved in activation and inactivation of the sodium channel.

Authors:  W Stühmer; F Conti; H Suzuki; X D Wang; M Noda; N Yahagi; H Kubo; S Numa
Journal:  Nature       Date:  1989-06-22       Impact factor: 49.962

4.  Successful treatment with tocainide of recessive generalized congenital myotonia.

Authors:  E W Streib
Journal:  Ann Neurol       Date:  1986-05       Impact factor: 10.422

5.  Improved therapy of myotonia with the lidocaine derivative tocainide.

Authors:  R Rüdel; R Dengler; K Ricker; A Haass; W Emser
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

6.  Hodgkin-Huxley parameters of the sodium channels in human myoballs.

Authors:  T Pröbstle; R Rüdel; J P Ruppersberg
Journal:  Pflugers Arch       Date:  1988-08       Impact factor: 3.657

7.  Binding affinity and stereoselectivity of local anesthetics in single batrachotoxin-activated Na+ channels.

Authors:  G K Wang
Journal:  J Gen Physiol       Date:  1990-11       Impact factor: 4.086

8.  Sodium channel mutations in paramyotonia congenita and hyperkalemic periodic paralysis.

Authors:  L J Ptacek; L Gouw; H Kwieciński; P McManis; J R Mendell; R J Barohn; A L George; R L Barchi; M Robertson; M F Leppert
Journal:  Ann Neurol       Date:  1993-03       Impact factor: 10.422

9.  Effects of tocainide enantiomers on experimental arrhythmias produced by programmed electrical stimulation.

Authors:  A C Uprichard; J D Allen; D W Harron
Journal:  J Cardiovasc Pharmacol       Date:  1988-02       Impact factor: 3.105

10.  Altered stereoselectivity of cocaine and bupivacaine isomers in normal and batrachotoxin-modified Na+ channels.

Authors:  G K Wang; S Y Wang
Journal:  J Gen Physiol       Date:  1992-12       Impact factor: 4.086

View more
  9 in total

Review 1.  Impact of stereoselectivity on the pharmacokinetics and pharmacodynamics of antiarrhythmic drugs.

Authors:  Reza Mehvar; Dion R Brocks; Majid Vakily
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of mexiletine.

Authors:  L Labbé; J Turgeon
Journal:  Clin Pharmacokinet       Date:  1999-11       Impact factor: 6.447

3.  Increased rigidity of the chiral centre of tocainide favours stereoselectivity and use-dependent block of skeletal muscle Na(+) channels enhancing the antimyotonic activity in vivo.

Authors:  S Talon; A De Luca; M De Bellis; J F Desaphy; G Lentini; A Scilimati; F Corbo; C Franchini; P Tortorella; H Jockusch; D Conte Camerino
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

4.  Inhibition of skeletal muscle sodium currents by mexiletine analogues: specific hydrophobic interactions rather than lipophilia per se account for drug therapeutic profile.

Authors:  Annamaria De Luca; Sophie Talon; Michela De Bellis; Jean-François Desaphy; Carlo Franchini; Giovanni Lentini; Alessia Catalano; Filomena Corbo; Vincenzo Tortorella; Diana Conte-Camerino
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-01-25       Impact factor: 3.000

5.  A practical and efficient route for the highly enantioselective synthesis of mexiletine analogues and novel beta-thiophenoxy and pyridyl ethers.

Authors:  Kun Huang; Margarita Ortiz-Marciales; Viatcheslav Stepanenko; Melvin De Jesús; Wildeliz Correa
Journal:  J Org Chem       Date:  2008-08-09       Impact factor: 4.354

6.  Evaluation of the pharmacological activity of the major mexiletine metabolites on skeletal muscle sodium currents.

Authors:  M De Bellis; A De Luca; F Rana; M M Cavalluzzi; A Catalano; G Lentini; C Franchini; V Tortorella; D Conte Camerino
Journal:  Br J Pharmacol       Date:  2006-08-21       Impact factor: 8.739

7.  Searching for novel anti-myotonic agents: pharmacophore requirement for use-dependent block of skeletal muscle sodium channels by N-benzylated cyclic derivatives of tocainide.

Authors:  Annamaria De Luca; Michela De Bellis; Filomena Corbo; Carlo Franchini; Marilena Muraglia; Alessia Catalano; Alessia Carocci; Diana Conte Camerino
Journal:  Neuromuscul Disord       Date:  2011-07-29       Impact factor: 4.296

8.  Combined modifications of mexiletine pharmacophores for new lead blockers of Na(v)1.4 channels.

Authors:  Michela De Bellis; Annamaria De Luca; Jean F Desaphy; Roberta Carbonara; Judith A Heiny; Ann Kennedy; Alessia Carocci; Maria M Cavalluzzi; Giovanni Lentini; Carlo Franchini; Diana Conte Camerino
Journal:  Biophys J       Date:  2013-01-22       Impact factor: 4.033

9.  Human-induced pluripotent stem cell-derived cardiomyocytes: Cardiovascular properties and metabolism and pharmacokinetics of deuterated mexiletine analogs.

Authors:  Jorge Gomez-Galeno; Karl Okolotowicz; Mark Johnson; Wesley L McKeithan; Mark Mercola; John R Cashman
Journal:  Pharmacol Res Perspect       Date:  2021-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.